These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33138638)

  • 1. Buccal Hydromorphone Syrup for Managing Dyspnea in Idiopathic Pulmonary Fibrosis.
    Fong S; Richman-Eisenstat J; Kalluri M
    Am J Hosp Palliat Care; 2021 Aug; 38(8):1046-1052. PubMed ID: 33138638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers.
    O'Donnell DE; Neder JA; Harle I; Moran-Mendoza O
    Expert Rev Respir Med; 2016 Dec; 10(12):1295-1303. PubMed ID: 27766905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing Dyspnea in Individuals With Idiopathic Pulmonary Fibrosis.
    Fenwick KE; Swan BA
    J Hosp Palliat Nurs; 2020 Dec; 22(6):447-455. PubMed ID: 32956191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.
    Khadawardi H; Mura M
    Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review.
    Kašiković Lečić S; Javorac J; Živanović D; Lovrenski A; Tegeltija D; Zvekić Svorcan J; Maksimović J
    Ups J Med Sci; 2022; 127():. PubMed ID: 35910492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30884853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
    Swigris JJ; Streiner DL; Brown KK; Belkin A; Green KE; Wamboldt FS;
    Respir Med; 2014 Jan; 108(1):181-8. PubMed ID: 24388667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspnea in idiopathic pulmonary fibrosis: a systematic review.
    Ryerson CJ; Donesky D; Pantilat SZ; Collard HR
    J Pain Symptom Manage; 2012 Apr; 43(4):771-82. PubMed ID: 22285287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D.
    Rautajoki T; Lehto JT; Sutinen E; Bergman P; Sintonen H; Rajala K; Mäkelä K; Hollmen M; Saarto T; Myllärniemi M
    J Palliat Med; 2023 Oct; 26(10):1357-1364. PubMed ID: 37366772
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and management of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Respir Investig; 2019 Jul; 57(4):300-311. PubMed ID: 30853366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis].
    Vainshelboim B; Kramer MR
    Harefuah; 2012 Apr; 151(4):220-4, 253. PubMed ID: 22616150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Novel Clinical Dyspnea Scale - A Retrospective Pilot Study.
    Kalluri M; Cui Y; Wang T; Bakal JA
    Am J Hosp Palliat Care; 2024 Mar; 41(3):253-261. PubMed ID: 36977656
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function.
    Zhang X; Li W; Li C; Zhang J; Su Z
    BMC Pulm Med; 2021 Apr; 21(1):122. PubMed ID: 33858421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Activation for Self-Management in Patients with Idiopathic Pulmonary Fibrosis or Sarcoidosis.
    Bloem AEM; Mostard RLM; Stoot N; Custers JWH; Vooijs M; Janssen DJA; van 't Hul AJ; Spruit MA
    Respiration; 2022; 101(1):76-83. PubMed ID: 34515234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.